At the American Society of Hematology Conference in Orlando, new results from the MajesTEC-3 study show that combining ...
Research has proven frozen blood platelets are safe and effective for use in critically injured patients—a breakthrough ...
The addition of ianalumab to eltrombopag significantly improved outcomes for patients with pretreated primary immune ...
An infant botulism outbreak has sickened at least 39 babies across the U.S. and underscored the crucial role of a medication ...
People who search for INUSpheresis are usually already dealing with complex, long lasting illness. Many live with long COVID, ...
Significant reduction in key neurodegeneration biomarker correlated with treatment response, suggesting neflamapimod may act on underlying disease CervoMed preparing to initiate Phase 3 registrational ...
Knee injuries are common in athletes, accounting for 41% of all athletic injuries. But knee injuries aren’t limited to ...
One complete response and three partial responses observed in heavily pretreated ICI-secondary refractory patients in high ...
Kelly Wyatt winced as a nurse unwrapped layers of gauze from her left leg, exposing the massive wound beneath. Yellow and red ...
One inspection was prompted by 'concerns about the quality of care', while another service was praised for major improvements ...
Data demonstrates neflamapimod treatment led to significant reductions in plasma glial fibrillary acidic protein ( GFAP), a key marker of neuroinflammation-associated neurodegeneration, and increased ...
Liv Hospital today announced the enhancement of its orthopedic surgery program, offering a wider range of diagnostic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results